Empowering enterprises with cutting-edge AI

At Nexus AI Solutions, we harness the power of artificial intelligence to drive innovation, efficiency, and accessibility across healthcare, entertainment, and assistive technology. We create AI-driven solutions that automate complex tasks, enhance productivity, and make technology more accessible — because the industries that shape lives deserve tools built for the stakes involved.

Request a Demo See Our Solutions
HC Healthcare ME Media AC Access A24 · Gaumont · Neon Voice · Eye-tracking UCB Pharma
Trusted by
Our Mission

Building AI that works where it matters most

We don't build general-purpose chatbots or incremental productivity tools. We build domain-specific AI systems for industries where the margin for error is thin and the potential impact is enormous — pharmaceutical research, global entertainment distribution, and human accessibility.

Every product is grounded in deep collaboration with the enterprises and communities that use it. Our AI doesn't just perform well in benchmarks — it performs well in the real-world conditions where it's deployed.

Solutions

Three products. Three industries. One principle: AI built for real-world stakes.

Each of our products targets a specific high-impact industry where generic AI tools fall short. We go deep — building custom models, integrating with existing workflows, and validating with domain experts — so the output is production-ready from day one.

Healthcare

Healthcare R&D Kit

An AI orchestration framework that deploys autonomous agents across the entire drug discovery pipeline. Traditional pharmaceutical R&D is one of the most resource-intensive processes in any industry — it typically takes 10 to 15 years and costs upwards of $2 billion to bring a single drug to market. Much of that time is spent on manual literature review, physical compound screening, and navigating fragmented datasets spread across genomic databases, chemical patent libraries, and electronic health records.

The Healthcare R&D Kit changes this equation. Our system ingests these massive, fragmented datasets simultaneously, cross-referencing findings across sources that researchers would normally spend months connecting manually. It uses multi-agent AI orchestration to identify novel drug targets, generate optimized molecular structures, predict compound viability, and even draft regulatory-ready documentation — all while maintaining the scientific rigor that pharmaceutical development demands.

  • Simultaneously ingests and cross-references genomic databases, chemical patent libraries, clinical trial data, and electronic health records
  • Generates optimized molecular structures and identifies novel drug targets using multi-agent AI orchestration
  • Predicts compound viability and drug-target interactions before physical screening, reducing costly lab iterations
  • Automates drafting of FDA regulatory submissions, clinical documentation, and compliance reports
  • Targeting a 50–70% reduction in the traditional 10–15 year drug development timeline
UCB Pharma Active pilot
DATA INGESTION Genomic · Patent · EHR AI ANALYSIS Autonomous Agents OUTPUT Molecules · Docs ⬡ Molecular Structure Optimized compound ◎ Drug Target Novel validated target ☰ Regulatory Draft FDA-ready documents 3–5 YEARS vs. traditional 10–15 years
Media & Entertainment

Nexus Dubber

AI-powered dubbing that doesn't flatten a performance. When a film crosses borders, traditional dubbing replaces the actor's voice with a stranger's — and in the process, it loses the subtlety, emotion, and personality that made the performance work. The result is a version of the film that technically speaks the right language but emotionally speaks a different one. Audiences notice, and engagement drops.

Nexus Dubber takes a fundamentally different approach. Our AI preserves the original actor's voice signature — their unique timbre, cadence, breathing patterns, and emotional delivery — while adapting the dialogue for a new language. The system handles lip-sync alignment and natural speech rhythm automatically, so the dubbed version doesn't just sound translated, it sounds performed. Studios get global distribution at a fraction of traditional dubbing costs and timelines, without sacrificing the creative integrity that defines their work.

  • Preserves the actor's original voice signature, timbre, breathing patterns, and emotional delivery across every language
  • Automatic lip-sync alignment and natural speech rhythm adaptation — the dubbed version looks and feels native
  • Scales from a single source to multi-language distribution, enabling simultaneous global releases
  • Dramatically reduces dubbing costs and turnaround times compared to traditional voice-actor re-recording
  • Production-grade output trusted by major independent film studios for theatrical and streaming releases
A24 Big Beach Gaumont Neon $250k+ contracts
ORIGINAL VOICE Nexus Dubber AI ES Spanish Same voice · Same emotion FR French Same voice · Same emotion JA Japanese Same voice · Same emotion One performance → Every language
Accessibility

Nexus Access

Over one billion people worldwide live with some form of disability, yet most accessibility tools are still workarounds rather than solutions. Screen readers describe what's on screen but can't act on it. Switch controls let you navigate an interface, but laboriously, one element at a time. These tools accommodate the computer's limitations — they don't transcend them.

Nexus Access takes a fundamentally different approach. It uses large language models to actually understand full computer environments — the operating system, running applications, open documents, browser tabs, and everything in between. Users interact through natural voice commands ("open my email and reply to the latest message from Sarah") and integrated eye-tracking for precise cursor control and selection. The AI interprets intent, not just words, and executes complex multi-step actions autonomously. The computer becomes an extension of the user's intent, not an obstacle to it.

  • LLM-powered deep understanding of any computer environment, application, and on-screen context
  • Natural voice command execution — speak in full sentences and natural language, not rigid command syntax or keyword triggers
  • Integrated eye-tracking for precise cursor control, element selection, and gaze-based scrolling
  • Executes complex multi-step actions autonomously — from composing emails to managing files to browsing the web
  • Works across operating systems and applications — not limited to specific software, browsers, or platforms
Launching soon
User Voice Command Eye Tracking LLM Engine Understands context Open Files Navigate freely Write Text Compose anything Browse Web Full control Full device control through natural interaction
3
AI products in market
50–70%
Faster drug development
$250k+
Enterprise contracts
6+
Studio & pharma partners
Contact

Let's talk about your challenge

Whether you're a pharmaceutical company looking to accelerate drug discovery, a film studio expanding into international markets, or an organization committed to making technology accessible to everyone — we'd love to hear from you. We build AI around your specific problem, not the other way around, and every engagement starts with understanding your goals.

admin@nexusaisolutionsllc.com
(251) 347-4780
30 N Gould St Ste N, Sheridan, WY 82801
LinkedIn
X (Twitter)

Send us a message

We respond within 2 business days.
FAQ

Common questions

We currently serve three verticals: pharmaceutical research and development (through our Healthcare R&D Kit), film and media production (through Nexus Dubber), and accessibility technology (through Nexus Access). Each product is purpose-built for its specific industry — we don't sell general-purpose AI toolkits or try to be everything to everyone. Our Healthcare R&D Kit works with pharmaceutical companies to accelerate the drug discovery pipeline. Nexus Dubber partners with film studios to deliver AI-powered dubbing that preserves the original performance. And Nexus Access is building the next generation of assistive technology for individuals with limited mobility. If your organization operates in any of these spaces, we'd love to discuss how we can help.
Most AI dubbing tools on the market today use text-to-speech synthesis to generate a new voice in the target language. The result sounds artificial — it loses the actor's unique timbre, breathing patterns, emotional nuance, and the micro-expressions that make a performance feel real. Nexus Dubber works differently. Instead of generating a new voice, our system preserves the original actor's voice signature and adapts it for the target language. It handles lip-sync alignment and natural speech rhythm automatically, so the dubbed version doesn't feel translated — it feels performed. The output is production-grade, which is why studios like A24, Big Beach, Gaumont, and Neon trust it for theatrical and streaming releases. We also dramatically reduce turnaround times and costs compared to traditional voice-actor re-recording sessions, enabling simultaneous multi-language releases.
The Healthcare R&D Kit is currently in an active pilot program with UCB Pharma, one of the world's leading biopharmaceutical companies. The pilot focuses on deploying our multi-agent AI orchestration system across the drug discovery pipeline, where it ingests and cross-references genomic databases, chemical patent libraries, clinical trial data, and electronic health records to identify novel drug targets and generate optimized molecular structures. Our target is a 50–70% reduction in the traditional 10–15 year drug development timeline. The system also automates the drafting of regulatory submissions and compliance documentation, reducing the administrative burden on research teams. We're actively seeking additional pharmaceutical and biotech partners who want to explore how AI can transform their R&D operations.
Nexus Access is currently in active development and will be launching soon. The product uses large language models to deeply understand full computer environments — including the operating system, open applications, browser tabs, and on-screen content — and execute complex multi-step actions through natural voice commands and integrated eye-tracking. Unlike existing accessibility tools that describe interfaces or navigate them one element at a time, Nexus Access interprets the user's intent and acts on it autonomously. We're building this in close collaboration with the accessibility community. If you'd like to be considered for early access, have a partnership proposal, or want to provide feedback on the product direction, please reach out through our contact form or email us directly.
We welcome conversations about strategic partnerships, technology integrations, distribution agreements, and investment opportunities. Whether you're a pharmaceutical company interested in piloting the Healthcare R&D Kit, a film studio or streaming platform looking to scale global distribution with Nexus Dubber, an accessibility-focused organization that wants to collaborate on Nexus Access, or an investor who sees the potential in domain-specific AI, we'd love to hear from you. Use our contact form below, or email us directly at admin@nexusaisolutionsllc.com. We respond to all inquiries within two business days.